Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$23,510,256
-$358,575 QoQ
Shares Held
92,571
-5.2% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.63%
of 13F equity value
Holder Rank
#673
of 4,676 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 58%
Shared 0%
None 42%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026COLDSTREAM CAPITAL MANAGEMENT INC holds $126,380,504 across 14 Drug Manufacturers - General names. JNJ ranks #2 (18.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
36,385 | $43,641,264 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
92,571 | $23,510,256 | |
| 3 | ABBV |
AbbVie Inc.
|
73,209 | $18,422,312 | |
| 4 | MRK |
Merck & Co., Inc.
|
123,237 | $15,835,954 | |
| 5 | AMGN |
Amgen Inc
|
19,733 | $7,145,713 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
35,562 | $4,492,903 | |
| 7 | NVS |
Novartis AG
|
17,467 | $2,737,428 | |
| 8 | PFE |
Pfizer Inc
|
110,237 | $2,654,506 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,510,256 | 92,571 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $23,868,831 | 97,647 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $20,109,330 | 97,170 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $17,737,648 | 95,662 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $13,308,954 | 87,129 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $13,209,653 | 79,653 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $7,004,814 | 48,436 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,808,699 | 48,184 | Shares | Sole | 2024-11-18 | |
| 2024-06-30 | $6,195,283 | 42,387 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $10,438,958 | 65,990 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $9,824,463 | 62,680 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $9,562,894 | 61,399 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $9,739,196 | 58,840 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $9,021,930 | 58,206 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $11,150,148 | 63,120 | Shares | Sole | 2023-01-10 | |
| 2022-06-30 | $11,082,126 | 62,431 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $10,074,462 | 56,844 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $9,867,317 | 57,680 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $6,800,280 | 42,107 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $7,285,955 | 44,227 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $7,132,790 | 43,400 | Shares | Sole | 2021-06-16 | |
| 2020-12-31 | $6,780,717 | 43,085 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $5,704,783 | 38,318 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $5,430,568 | 38,616 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $5,299,487 | 40,414 | Shares | Sole | 2020-05-27 | |
| No filing history on record for this holder in this stock. | ||||||